Screening younger women with a family history of breast cancer - does early detection improve outcome?

European Journal of Cancer

Volumn 42, Issue 10, 2006, Pages 1385-1390

  Maurice, A ^a   Evans, D G R ^a,b   Shenton, A ^b   Ashcroft, L ^e   Baildam, A ^c   Barr, L ^c   Byrne, G ^c   Bundred, N ^c   Boggis, C ^c   Wilson, M ^c   Duffy, S W ^d   Howell, A ^a,e  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

BRCA1; BRCA2; Breast cancer; Mammography; Screening; Surveillance; Survival

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FAMILY HISTORY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; EARLY DIAGNOSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PEDIGREE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745132459     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.01.055     Document Type: Article

References (27)

1. Botha J.L., Bray F., Sankila R., and Parkin D.M. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39 (2003) 1818-1829
2. Claus E.B., Risch N.J., and Thompson W.D. Age of onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131 (1990) 961-972
3. Mokbel K. Breast cancer prevention. Br J GP 52 (2002) 972-973
4. Willett L.R., August D.A., and Carson J.L. Breast Cancer Prevention. New options for patients and clinicians. New Jersey Medicine 99 (2002) 27-34
5. th September 2002.
6. Rebbeck T.R., Friebel T., Lynch H.T., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22 (2004) 1055-1062
7. Cuzick J., Powles T., Veronesi U., Forbes J., Edwards R., Ashley S., et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 361 (2003) 296-300
8. McTiernan A. Behavioral risk factors in breast cancer: can risk be modified?. Oncologist 8 (2003) 326-334
9. Tilanus-Linthorst M.M.A., Bartels C.C.M., Obdeijn A.I.M., and Oudkerk M. Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 36 (2000) 514-519
10. Kollias J., Sibbering D.M., Blamey R.W., Holland P.A.M., Obuszko Z., Wilson A.R.M., et al. Screening women aged less than 50 years with a family history of breast cancer. Eur J Cancer 34 (1998) 878-883
11. MacMillian R.D., and on behalf of The British Familial Breast Cancer Group. Screening women with a family history of breast cancer. Eur J Surg Oncol 26 (2000) 149-152
12. Myles J., Duffy S., Nixon R., Boggis C., Howell A., Shenton A., et al. Initial results of a study into the effectiveness of breast cancer screening in a population identified to be at high risk. Rev Epidemiol Sante Publique 49 (2001) 471-475
13. Nixon R.M., Pharoah P., Tabar L., et al. Mammographic screening in women with a family history of breast cancer: some results from the Swedish Two-County Trial. Rev Epidemiol Sante Publique 48 (2000) 325-331
14. Tabar L., Yen M.-.F., Bedrich V., Chen H.-.H.T., Smith R.A., and Duffy S.W. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361 (2003) 1405-1410
15. Lalloo F., Boggis C.R., Evans D.G., Shenton A., Threlfall A.G., and Howell A. Screening by mammography, women with a family history of breast cancer. Eur J Cancer 34 (1998) 937-940
16. Moss S. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. J Med Screening 6 (1999) 144-148
17. Stoppa-Lyonnet D., Ansquer Y., Dreyfus H., Gautier C., Gauthier-Villars M., Bourstyn E., et al. Familial invasive breast cancers: worse outcome related to BRCA 1 mutations. J Clin Onc 18 (2000) 4053-4059
18. Evans D.G., and Howell A. Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?. Breast Cancer Res 6 (2004) E7
19. Breast Screening Programme Annual Review 2002. Department of Health, UK.
20. Page D.L., Dupont W.D., Rogers L.W., Jensen R.A., and Schuyler P.A. Continued local recurrence of carcinoma 15-25 years after diagnosis of low grade ductal carcinoma in-situ of the breast treated by biopsy only. Cancer 76 (1995) 1197-1200
21. Dupont W.D., and Page D.L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312 Jan (1985) 146-151
22. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet. 1997 May 24;349:1505-10.
23. Stockton D., Davies T., Day N., and McCann J. Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment. Br Med J 314 (1997) 472-475
24. McIntosh A, Shaw C, Evans G, Turnbull N, Bahar N, Barclay M, et al. Clinical Guidelines and Evidence Review for The Classification and Care of Women at Risk of Familial Breast Cancer, London: National Collaborating Centre for Primary Care/University of Sheffield. NICE guideline CG014, 2004. www.nice.org.uk.
25. Leach M.O., Boggis C.R., Dixon A.K., Easton D.F., Eeles R.A., Evans D.G., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 9473 (2005) 1869-1878
26. Mackay J., Rogers C., Fielder H., Blamey R., Macmillan D., Boggis C., et al. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. J Epidemiol Biostat 6 (2001) 365-369
27. Day N.E., and Walter S.D. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 40 (1984) 1-14